Most bought healthcare stocks in Q2 2025
See which Healthcare stocks institutional investors increased the most in Q2 2025, measured as net growth in reported share positions from Q1 2025 into Q2 2025. Notable additions at the top of this list include UNITEDHEALTH GROUP INC (UNH), AVANTOR INC (AVTR), DANAHER CORP (DHR), EVOLENT HEALTH INC - A (EVH). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15,197,137 | $1.89B | 6 | 10 | 7 | 6 | 25 |
| AVTR | AVANTOR INC | 14,347,941 | -$95.60M | 2 | 2 | 0 | 2 | 4 |
| DHR | DANAHER CORP | 8,541,001 | $1.63B | 2 | 5 | 1 | 1 | 13 |
| EVH | EVOLENT HEALTH INC - A | 7,098,293 | $89.20M | 1 | 1 | 0 | 0 | 2 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 6,667,504 | $375.70M | 0 | 3 | 0 | 1 | 6 |
| OPCH | OPTION CARE HEALTH INC | 4,822,688 | $145.11M | 0 | 2 | 0 | 0 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | 3,671,327 | $1.62M | 0 | 1 | 0 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | 3,548,366 | $293.84M | 1 | 3 | 3 | 1 | 7 |
| BSX | BOSTON SCIENTIFIC CORP | 3,156,942 | $359.88M | 1 | 5 | 1 | 0 | 7 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,552,622 | -$278.64M | 0 | 3 | 0 | 0 | 3 |
| BLCO | BAUSCH + LOMB CORP | 2,458,245 | $26.67M | 1 | 0 | 0 | 1 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 2,452,023 | -$252.73M | 0 | 4 | 6 | 0 | 10 |
| MRSN | MERSANA THERAPEUTICS INC | 2,010,275 | $554.56K | 0 | 1 | 0 | 0 | 1 |
| HUM | HUMANA INC | 1,922,020 | $109.36M | 0 | 5 | 0 | 1 | 5 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,921,516 | $18.10M | 0 | 1 | 0 | 0 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 1,829,090 | $59.76M | 0 | 2 | 0 | 0 | 2 |
| REGN | REGENERON PHARMACEUTICALS | 1,531,463 | $516.64M | 2 | 3 | 2 | 1 | 7 |
| GH | GUARDANT HEALTH INC | 1,483,264 | $96.31M | 1 | 2 | 0 | 0 | 3 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 1,415,540 | $560.60M | 1 | 3 | 4 | 0 | 9 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,375,800 | -$3.29M | 0 | 1 | 0 | 0 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,165,283 | $72.19M | 0 | 5 | 0 | 0 | 5 |
| GOSS | GOSSAMER BIO INC | 1,163,139 | $1.65M | 0 | 1 | 0 | 0 | 2 |
| ARVN | ARVINAS INC | 1,082,055 | $8.01M | 0 | 1 | 0 | 0 | 1 |
| OVID | OVID THERAPEUTICS INC | 1,071,509 | $371.92K | 0 | 1 | 0 | 0 | 1 |
| BIO | BIO-RAD LABORATORIES-A | 1,035,674 | $243.36M | 0 | 2 | 2 | 0 | 4 |
| GSK | GSK PLC-SPON ADR | 1,028,504 | $11.61M | 2 | 3 | 3 | 0 | 8 |
| COR | CENCORA INC | 1,013,188 | $327.34M | 0 | 2 | 1 | 1 | 3 |
| EXEL | EXELIXIS INC | 1,003,301 | $150.43M | 1 | 2 | 0 | 0 | 3 |
| XRAY | DENTSPLY SIRONA INC | 916,366 | $28.52M | 0 | 3 | 1 | 0 | 4 |
| CCCC | C4 THERAPEUTICS INC | 878,688 | $1.22M | 0 | 1 | 0 | 0 | 1 |
| BAX | BAXTER INTERNATIONAL INC | 873,105 | -$342.04M | 0 | 3 | 5 | 1 | 8 |
| VERV | VERVE THERAPEUTICS INC | 866,800 | $10.94M | 0 | 1 | 0 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | 857,459 | -$33.94M | 1 | 5 | 5 | 2 | 11 |
| CPRX | CATALYST PHARMACEUTICALS INC | 853,012 | $5.49M | 0 | 2 | 0 | 0 | 2 |
| IPSC | CENTURY THERAPEUTICS INC | 837,182 | $565.76K | 0 | 1 | 0 | 0 | 1 |
| MASI | MASIMO CORP | 816,082 | $139.13M | 1 | 2 | 0 | 0 | 3 |
| IDXX | IDEXX LABORATORIES INC | 811,374 | $894.36M | 1 | 3 | 4 | 1 | 8 |
| TDOC | TELADOC HEALTH INC | 775,300 | $11.66M | 0 | 1 | 0 | 0 | 1 |
| BKD | BROOKDALE SENIOR LIVING INC | 762,131 | $11.07M | 1 | 1 | 1 | 0 | 3 |
| ABBV | ABBVIE INC | 732,137 | $98.82M | 0 | 4 | 3 | 1 | 11 |
| CTMX | CYTOMX THERAPEUTICS INC | 706,200 | $3.49M | 0 | 1 | 0 | 0 | 1 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 703,512 | $460.88K | 0 | 1 | 0 | 0 | 1 |
| GBIO | GENERATION BIO CO | 700,110 | $64.44K | 0 | 1 | 0 | 0 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 683,761 | $35.95M | 1 | 1 | 0 | 0 | 2 |
| OABI | OMNIAB INC | 680,950 | $1.17M | 0 | 1 | 0 | 0 | 1 |
| BPMC | BLUEPRINT MEDICINES CORP | 674,436 | $87.11M | 1 | 0 | 1 | 0 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 654,200 | $2.70M | 0 | 1 | 0 | 0 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 652,100 | $3.74M | 0 | 1 | 0 | 0 | 1 |
| IMNN | IMUNON INC | 627,558 | $499.44K | 0 | 1 | 0 | 0 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 624,478 | $10.68M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2025
What are the most bought Healthcare stocks in Q2 2025?
The most bought healthcare stocks in Q2 2025 are those with the largest increase in reported share counts across tracked institutional investors compared to Q1 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2025?
Among the managers we track, net additions were largest in companies such as UNITEDHEALTH GROUP INC (UNH), AVANTOR INC (AVTR), DANAHER CORP (DHR), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2025).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.